The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2024 | Addressing challenges in collecting cardiac toxicity data: NI-HEART analysis
Gerard Walls, MB MRCP MSc FRCR, Queens University in Belfast, UK, discusses the NI-HEART analysis aimed at addressing the challenges of collecting cardiac toxicity events after curative intent radiotherapy in lung cancer. Leveraging Northern Ireland’s integrated electronic healthcare system, the study successfully captured health events post-radiotherapy. Dr Walls highlights the importance of addressing unknowns regarding cardiotoxicity in lung cancer radiotherapy, utilizing expertise from Belfast and connections across the UK and Ireland. This interview took place at the BTOG 2024 congress in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
